nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC22A2—Vinblastine—testicular cancer	0.0984	0.522	CbGbCtD
Amiloride—SLC22A2—Cisplatin—testicular cancer	0.0902	0.478	CbGbCtD
Amiloride—AOC1—embryo—testicular cancer	0.0246	0.077	CbGeAlD
Amiloride—SLC9A1—embryo—testicular cancer	0.0236	0.0737	CbGeAlD
Amiloride—SCNN1G—seminal vesicle—testicular cancer	0.0235	0.0736	CbGeAlD
Amiloride—PLAU—seminal vesicle—testicular cancer	0.021	0.0656	CbGeAlD
Amiloride—SCNN1D—gonad—testicular cancer	0.017	0.0532	CbGeAlD
Amiloride—SCNN1B—gonad—testicular cancer	0.0144	0.045	CbGeAlD
Amiloride—ASIC1—female gonad—testicular cancer	0.0136	0.0424	CbGeAlD
Amiloride—SLC9A1—female gonad—testicular cancer	0.013	0.0407	CbGeAlD
Amiloride—PLAU—female gonad—testicular cancer	0.0123	0.0385	CbGeAlD
Amiloride—SCNN1D—testis—testicular cancer	0.0123	0.0384	CbGeAlD
Amiloride—AOC1—testis—testicular cancer	0.012	0.0376	CbGeAlD
Amiloride—ASIC1—testis—testicular cancer	0.012	0.0376	CbGeAlD
Amiloride—SLC9A1—testis—testicular cancer	0.0115	0.0361	CbGeAlD
Amiloride—PLAU—testis—testicular cancer	0.0109	0.0342	CbGeAlD
Amiloride—SCNN1A—female gonad—testicular cancer	0.0108	0.0338	CbGeAlD
Amiloride—SCNN1B—testis—testicular cancer	0.0104	0.0324	CbGeAlD
Amiloride—SCNN1A—testis—testicular cancer	0.00957	0.0299	CbGeAlD
Amiloride—SCNN1D—lymph node—testicular cancer	0.00888	0.0278	CbGeAlD
Amiloride—ASIC1—lymph node—testicular cancer	0.00872	0.0273	CbGeAlD
Amiloride—AOC1—lymph node—testicular cancer	0.00872	0.0273	CbGeAlD
Amiloride—SLC9A1—lymph node—testicular cancer	0.00835	0.0261	CbGeAlD
Amiloride—PLAU—lymph node—testicular cancer	0.00792	0.0248	CbGeAlD
Amiloride—SCNN1B—lymph node—testicular cancer	0.00751	0.0235	CbGeAlD
Amiloride—SLC22A4—seminal vesicle—testicular cancer	0.00736	0.023	CbGeAlD
Amiloride—SCNN1A—lymph node—testicular cancer	0.00693	0.0217	CbGeAlD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00445	0.0729	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00441	0.0722	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00438	0.0717	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00337	0.0552	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00337	0.0552	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00337	0.0552	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00337	0.0552	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00337	0.0552	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—MMP2—testicular cancer	0.00319	0.0523	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—MMP2—testicular cancer	0.00311	0.051	CbGpPWpGaD
Amiloride—SLC22A4—lymph node—testicular cancer	0.00278	0.00869	CbGeAlD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.00277	0.0454	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—FGFR3—testicular cancer	0.00252	0.0412	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00223	0.0364	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—FGFR3—testicular cancer	0.0022	0.036	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00209	0.0341	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.002	0.0328	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00194	0.0318	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—MMP2—testicular cancer	0.00191	0.0312	CbGpPWpGaD
Amiloride—Paraesthesia—Bleomycin—testicular cancer	0.00124	0.00289	CcSEcCtD
Amiloride—Coma—Doxorubicin—testicular cancer	0.00124	0.00288	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.00124	0.0203	CbGpPWpGaD
Amiloride—Dyspnoea—Bleomycin—testicular cancer	0.00123	0.00286	CcSEcCtD
Amiloride—Arthralgia—Ifosfamide—testicular cancer	0.00123	0.00286	CcSEcCtD
Amiloride—Chest pain—Ifosfamide—testicular cancer	0.00123	0.00286	CcSEcCtD
Amiloride—Flatulence—Cisplatin—testicular cancer	0.00123	0.00286	CcSEcCtD
Amiloride—Anorexia—Dactinomycin—testicular cancer	0.00123	0.00286	CcSEcCtD
Amiloride—Diarrhoea—Chlorambucil—testicular cancer	0.00122	0.00284	CcSEcCtD
Amiloride—Hepatic function abnormal—Epirubicin—testicular cancer	0.00122	0.00283	CcSEcCtD
Amiloride—Decreased appetite—Bleomycin—testicular cancer	0.0012	0.00279	CcSEcCtD
Amiloride—Visual disturbance—Methotrexate—testicular cancer	0.0012	0.00279	CcSEcCtD
Amiloride—Muscle spasms—Cisplatin—testicular cancer	0.0012	0.00279	CcSEcCtD
Amiloride—Confusional state—Ifosfamide—testicular cancer	0.00119	0.00277	CcSEcCtD
Amiloride—Pain—Bleomycin—testicular cancer	0.00118	0.00275	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00118	0.00273	CcSEcCtD
Amiloride—Asthenia—Vinblastine—testicular cancer	0.00118	0.00273	CcSEcCtD
Amiloride—Tremor—Cisplatin—testicular cancer	0.00117	0.00272	CcSEcCtD
Amiloride—Alopecia—Etoposide—testicular cancer	0.00116	0.0027	CcSEcCtD
Amiloride—Feeling abnormal—Bleomycin—testicular cancer	0.00114	0.00265	CcSEcCtD
Amiloride—Vomiting—Chlorambucil—testicular cancer	0.00114	0.00264	CcSEcCtD
Amiloride—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00113	0.00262	CcSEcCtD
Amiloride—Anorexia—Ifosfamide—testicular cancer	0.00113	0.00262	CcSEcCtD
Amiloride—Decreased appetite—Dactinomycin—testicular cancer	0.00112	0.00261	CcSEcCtD
Amiloride—Diarrhoea—Vinblastine—testicular cancer	0.00112	0.0026	CcSEcCtD
Amiloride—Fatigue—Dactinomycin—testicular cancer	0.00111	0.00258	CcSEcCtD
Amiloride—Back pain—Etoposide—testicular cancer	0.00111	0.00257	CcSEcCtD
Amiloride—Pain—Dactinomycin—testicular cancer	0.0011	0.00256	CcSEcCtD
Amiloride—Muscle spasms—Etoposide—testicular cancer	0.0011	0.00256	CcSEcCtD
Amiloride—Dizziness—Vinblastine—testicular cancer	0.00108	0.00252	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00108	0.0025	CcSEcCtD
Amiloride—Hyponatraemia—Epirubicin—testicular cancer	0.00107	0.00248	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.00107	0.00247	CcSEcCtD
Amiloride—Pain in extremity—Epirubicin—testicular cancer	0.00107	0.00247	CcSEcCtD
Amiloride—Feeling abnormal—Dactinomycin—testicular cancer	0.00106	0.00247	CcSEcCtD
Amiloride—Nausea—Chlorambucil—testicular cancer	0.00106	0.00247	CcSEcCtD
Amiloride—Paraesthesia—Ifosfamide—testicular cancer	0.00106	0.00247	CcSEcCtD
Amiloride—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00106	0.00245	CcSEcCtD
Amiloride—Dyspnoea—Ifosfamide—testicular cancer	0.00105	0.00245	CcSEcCtD
Amiloride—Somnolence—Ifosfamide—testicular cancer	0.00105	0.00244	CcSEcCtD
Amiloride—Vomiting—Vinblastine—testicular cancer	0.00104	0.00242	CcSEcCtD
Amiloride—Vertigo—Etoposide—testicular cancer	0.00103	0.00239	CcSEcCtD
Amiloride—Decreased appetite—Ifosfamide—testicular cancer	0.00103	0.00239	CcSEcCtD
Amiloride—Headache—Vinblastine—testicular cancer	0.00103	0.00238	CcSEcCtD
Amiloride—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00102	0.00237	CcSEcCtD
Amiloride—Abdominal pain—Dactinomycin—testicular cancer	0.00102	0.00237	CcSEcCtD
Amiloride—Fatigue—Ifosfamide—testicular cancer	0.00102	0.00237	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00102	0.0167	CbGpPWpGaD
Amiloride—Pain—Ifosfamide—testicular cancer	0.00101	0.00235	CcSEcCtD
Amiloride—Constipation—Ifosfamide—testicular cancer	0.00101	0.00235	CcSEcCtD
Amiloride—Cough—Etoposide—testicular cancer	0.000999	0.00232	CcSEcCtD
Amiloride—Asthenia—Bleomycin—testicular cancer	0.000993	0.00231	CcSEcCtD
Amiloride—Hyponatraemia—Doxorubicin—testicular cancer	0.00099	0.0023	CcSEcCtD
Amiloride—Pain in extremity—Doxorubicin—testicular cancer	0.000986	0.00229	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000986	0.00229	CcSEcCtD
Amiloride—Pruritus—Bleomycin—testicular cancer	0.000979	0.00227	CcSEcCtD
Amiloride—Feeling abnormal—Ifosfamide—testicular cancer	0.000975	0.00226	CcSEcCtD
Amiloride—Chest pain—Etoposide—testicular cancer	0.000975	0.00226	CcSEcCtD
Amiloride—Nausea—Vinblastine—testicular cancer	0.000973	0.00226	CcSEcCtD
Amiloride—Orthostatic hypotension—Epirubicin—testicular cancer	0.000973	0.00226	CcSEcCtD
Amiloride—Anorexia—Cisplatin—testicular cancer	0.000972	0.00226	CcSEcCtD
Amiloride—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000967	0.00225	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000948	0.0155	CbGpPWpGaD
Amiloride—Confusional state—Etoposide—testicular cancer	0.000942	0.00219	CcSEcCtD
Amiloride—Muscular weakness—Epirubicin—testicular cancer	0.00094	0.00218	CcSEcCtD
Amiloride—Abdominal pain—Ifosfamide—testicular cancer	0.000935	0.00217	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000929	0.00216	CcSEcCtD
Amiloride—Abdominal distension—Epirubicin—testicular cancer	0.000927	0.00215	CcSEcCtD
Amiloride—Asthenia—Dactinomycin—testicular cancer	0.000926	0.00215	CcSEcCtD
Amiloride—Neutropenia—Methotrexate—testicular cancer	0.00092	0.00214	CcSEcCtD
Amiloride—Dysuria—Methotrexate—testicular cancer	0.00092	0.00214	CcSEcCtD
Amiloride—Paraesthesia—Cisplatin—testicular cancer	0.000916	0.00213	CcSEcCtD
Amiloride—Dyspnoea—Cisplatin—testicular cancer	0.000909	0.00211	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—testicular cancer	0.000906	0.0021	CcSEcCtD
Amiloride—Orthostatic hypotension—Doxorubicin—testicular cancer	0.0009	0.00209	CcSEcCtD
Amiloride—Angina pectoris—Epirubicin—testicular cancer	0.000897	0.00208	CcSEcCtD
Amiloride—Anorexia—Etoposide—testicular cancer	0.000891	0.00207	CcSEcCtD
Amiloride—Decreased appetite—Cisplatin—testicular cancer	0.000886	0.00206	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000883	0.0145	CbGpPWpGaD
Amiloride—Diarrhoea—Dactinomycin—testicular cancer	0.000883	0.00205	CcSEcCtD
Amiloride—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00088	0.00204	CcSEcCtD
Amiloride—Vomiting—Bleomycin—testicular cancer	0.00088	0.00204	CcSEcCtD
Amiloride—Depression—Methotrexate—testicular cancer	0.000875	0.00203	CcSEcCtD
Amiloride—Rash—Bleomycin—testicular cancer	0.000873	0.00203	CcSEcCtD
Amiloride—Pain—Cisplatin—testicular cancer	0.000872	0.00202	CcSEcCtD
Amiloride—Dermatitis—Bleomycin—testicular cancer	0.000872	0.00202	CcSEcCtD
Amiloride—Muscular weakness—Doxorubicin—testicular cancer	0.00087	0.00202	CcSEcCtD
Amiloride—Dysuria—Epirubicin—testicular cancer	0.000861	0.002	CcSEcCtD
Amiloride—Neutropenia—Epirubicin—testicular cancer	0.000861	0.002	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—testicular cancer	0.000858	0.00199	CcSEcCtD
Amiloride—Pollakiuria—Epirubicin—testicular cancer	0.000851	0.00198	CcSEcCtD
Amiloride—Asthenia—Ifosfamide—testicular cancer	0.000849	0.00197	CcSEcCtD
Amiloride—Feeling abnormal—Cisplatin—testicular cancer	0.00084	0.00195	CcSEcCtD
Amiloride—Paraesthesia—Etoposide—testicular cancer	0.000839	0.00195	CcSEcCtD
Amiloride—Pruritus—Ifosfamide—testicular cancer	0.000837	0.00194	CcSEcCtD
Amiloride—Dyspnoea—Etoposide—testicular cancer	0.000833	0.00193	CcSEcCtD
Amiloride—Somnolence—Etoposide—testicular cancer	0.000831	0.00193	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—testicular cancer	0.00083	0.00193	CcSEcCtD
Amiloride—Nausea—Bleomycin—testicular cancer	0.000822	0.00191	CcSEcCtD
Amiloride—Vomiting—Dactinomycin—testicular cancer	0.000821	0.00191	CcSEcCtD
Amiloride—Rash—Dactinomycin—testicular cancer	0.000814	0.00189	CcSEcCtD
Amiloride—Decreased appetite—Etoposide—testicular cancer	0.000812	0.00189	CcSEcCtD
Amiloride—Diarrhoea—Ifosfamide—testicular cancer	0.000809	0.00188	CcSEcCtD
Amiloride—Gastrointestinal disorder—Etoposide—testicular cancer	0.000807	0.00187	CcSEcCtD
Amiloride—Fatigue—Etoposide—testicular cancer	0.000805	0.00187	CcSEcCtD
Amiloride—Jaundice—Epirubicin—testicular cancer	0.0008	0.00186	CcSEcCtD
Amiloride—Constipation—Etoposide—testicular cancer	0.000799	0.00185	CcSEcCtD
Amiloride—Pain—Etoposide—testicular cancer	0.000799	0.00185	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—testicular cancer	0.000797	0.00185	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—testicular cancer	0.000797	0.00185	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—testicular cancer	0.000792	0.00184	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—testicular cancer	0.000788	0.00183	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—testicular cancer	0.000787	0.00183	CcSEcCtD
Amiloride—Dizziness—Ifosfamide—testicular cancer	0.000782	0.00182	CcSEcCtD
Amiloride—Feeling abnormal—Etoposide—testicular cancer	0.00077	0.00179	CcSEcCtD
Amiloride—Nausea—Dactinomycin—testicular cancer	0.000767	0.00178	CcSEcCtD
Amiloride—Gastrointestinal pain—Etoposide—testicular cancer	0.000764	0.00177	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—testicular cancer	0.000759	0.00176	CcSEcCtD
Amiloride—Vomiting—Ifosfamide—testicular cancer	0.000752	0.00175	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—testicular cancer	0.00075	0.00174	CcSEcCtD
Amiloride—Rash—Ifosfamide—testicular cancer	0.000746	0.00173	CcSEcCtD
Amiloride—Dermatitis—Ifosfamide—testicular cancer	0.000745	0.00173	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—testicular cancer	0.000741	0.00172	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—testicular cancer	0.000741	0.00172	CcSEcCtD
Amiloride—Abdominal pain—Etoposide—testicular cancer	0.000739	0.00171	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—testicular cancer	0.000737	0.00171	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—testicular cancer	0.000734	0.00171	CcSEcCtD
Amiloride—Asthenia—Cisplatin—testicular cancer	0.000732	0.0017	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—testicular cancer	0.00071	0.00165	CcSEcCtD
Amiloride—Nausea—Ifosfamide—testicular cancer	0.000703	0.00163	CcSEcCtD
Amiloride—Diarrhoea—Cisplatin—testicular cancer	0.000698	0.00162	CcSEcCtD
Amiloride—Alopecia—Methotrexate—testicular cancer	0.000696	0.00162	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—testicular cancer	0.000694	0.00161	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—testicular cancer	0.000687	0.0016	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—testicular cancer	0.000686	0.00159	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—testicular cancer	0.000682	0.00158	CcSEcCtD
Amiloride—Asthenia—Etoposide—testicular cancer	0.00067	0.00156	CcSEcCtD
Amiloride—Back pain—Methotrexate—testicular cancer	0.000663	0.00154	CcSEcCtD
Amiloride—Pruritus—Etoposide—testicular cancer	0.000661	0.00153	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—testicular cancer	0.000657	0.00153	CcSEcCtD
Amiloride—Alopecia—Epirubicin—testicular cancer	0.000651	0.00151	CcSEcCtD
Amiloride—Vomiting—Cisplatin—testicular cancer	0.000648	0.00151	CcSEcCtD
Amiloride—Rash—Cisplatin—testicular cancer	0.000643	0.00149	CcSEcCtD
Amiloride—Dermatitis—Cisplatin—testicular cancer	0.000642	0.00149	CcSEcCtD
Amiloride—Diarrhoea—Etoposide—testicular cancer	0.000639	0.00148	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—testicular cancer	0.000636	0.00148	CcSEcCtD
Amiloride—Flatulence—Epirubicin—testicular cancer	0.000632	0.00147	CcSEcCtD
Amiloride—Tension—Epirubicin—testicular cancer	0.00063	0.00146	CcSEcCtD
Amiloride—Nervousness—Epirubicin—testicular cancer	0.000623	0.00145	CcSEcCtD
Amiloride—Back pain—Epirubicin—testicular cancer	0.000621	0.00144	CcSEcCtD
Amiloride—Dizziness—Etoposide—testicular cancer	0.000618	0.00143	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—testicular cancer	0.000617	0.00143	CcSEcCtD
Amiloride—Vertigo—Methotrexate—testicular cancer	0.000616	0.00143	CcSEcCtD
Amiloride—Nausea—Cisplatin—testicular cancer	0.000606	0.00141	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—testicular cancer	0.000603	0.0014	CcSEcCtD
Amiloride—Cough—Methotrexate—testicular cancer	0.000598	0.00139	CcSEcCtD
Amiloride—Vomiting—Etoposide—testicular cancer	0.000594	0.00138	CcSEcCtD
Amiloride—Rash—Etoposide—testicular cancer	0.000589	0.00137	CcSEcCtD
Amiloride—Dermatitis—Etoposide—testicular cancer	0.000589	0.00137	CcSEcCtD
Amiloride—Headache—Etoposide—testicular cancer	0.000585	0.00136	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—testicular cancer	0.000585	0.00136	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—testicular cancer	0.000584	0.00136	CcSEcCtD
Amiloride—Chest pain—Methotrexate—testicular cancer	0.000584	0.00136	CcSEcCtD
Amiloride—Tension—Doxorubicin—testicular cancer	0.000583	0.00135	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—testicular cancer	0.000577	0.00134	CcSEcCtD
Amiloride—Vertigo—Epirubicin—testicular cancer	0.000577	0.00134	CcSEcCtD
Amiloride—Back pain—Doxorubicin—testicular cancer	0.000574	0.00133	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—testicular cancer	0.000571	0.00133	CcSEcCtD
Amiloride—Palpitations—Epirubicin—testicular cancer	0.000567	0.00132	CcSEcCtD
Amiloride—Confusional state—Methotrexate—testicular cancer	0.000564	0.00131	CcSEcCtD
Amiloride—Cough—Epirubicin—testicular cancer	0.00056	0.0013	CcSEcCtD
Amiloride—Nausea—Etoposide—testicular cancer	0.000555	0.00129	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—testicular cancer	0.000546	0.00127	CcSEcCtD
Amiloride—Chest pain—Epirubicin—testicular cancer	0.000546	0.00127	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—testicular cancer	0.000533	0.00124	CcSEcCtD
Amiloride—Anorexia—Methotrexate—testicular cancer	0.000533	0.00124	CcSEcCtD
Amiloride—Confusional state—Epirubicin—testicular cancer	0.000528	0.00123	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—testicular cancer	0.000525	0.00122	CcSEcCtD
Amiloride—Cough—Doxorubicin—testicular cancer	0.000518	0.0012	CcSEcCtD
Amiloride—Shock—Epirubicin—testicular cancer	0.000515	0.0012	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00051	0.00118	CcSEcCtD
Amiloride—Insomnia—Methotrexate—testicular cancer	0.000506	0.00118	CcSEcCtD
Amiloride—Arthralgia—Doxorubicin—testicular cancer	0.000505	0.00117	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—testicular cancer	0.000505	0.00117	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—testicular cancer	0.000502	0.00117	CcSEcCtD
Amiloride—Anorexia—Epirubicin—testicular cancer	0.000499	0.00116	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—testicular cancer	0.000499	0.00116	CcSEcCtD
Amiloride—Somnolence—Methotrexate—testicular cancer	0.000497	0.00116	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—testicular cancer	0.000493	0.00114	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—testicular cancer	0.000489	0.00113	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—testicular cancer	0.000486	0.00113	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000483	0.00112	CcSEcCtD
Amiloride—Fatigue—Methotrexate—testicular cancer	0.000482	0.00112	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000482	0.00788	CbGpPWpGaD
Amiloride—Pain—Methotrexate—testicular cancer	0.000479	0.00111	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000477	0.00111	CcSEcCtD
Amiloride—Shock—Doxorubicin—testicular cancer	0.000477	0.00111	CcSEcCtD
Amiloride—Insomnia—Epirubicin—testicular cancer	0.000474	0.0011	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—testicular cancer	0.00047	0.00109	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—testicular cancer	0.000467	0.00108	CcSEcCtD
Amiloride—Somnolence—Epirubicin—testicular cancer	0.000466	0.00108	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—testicular cancer	0.000462	0.00107	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—testicular cancer	0.000461	0.00107	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—testicular cancer	0.000461	0.00107	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—testicular cancer	0.000458	0.00106	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—testicular cancer	0.000455	0.00106	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000452	0.00105	CcSEcCtD
Amiloride—Fatigue—Epirubicin—testicular cancer	0.000452	0.00105	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000449	0.00735	CbGpPWpGaD
Amiloride—Pain—Epirubicin—testicular cancer	0.000448	0.00104	CcSEcCtD
Amiloride—Constipation—Epirubicin—testicular cancer	0.000448	0.00104	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—testicular cancer	0.000442	0.00103	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000441	0.00103	CcSEcCtD
Amiloride—Insomnia—Doxorubicin—testicular cancer	0.000438	0.00102	CcSEcCtD
Amiloride—Paraesthesia—Doxorubicin—testicular cancer	0.000435	0.00101	CcSEcCtD
Amiloride—Dyspnoea—Doxorubicin—testicular cancer	0.000432	0.001	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—testicular cancer	0.000432	0.001	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—testicular cancer	0.000431	0.001	CcSEcCtD
Amiloride—Gastrointestinal pain—Epirubicin—testicular cancer	0.000428	0.000994	CcSEcCtD
Amiloride—Dyspepsia—Doxorubicin—testicular cancer	0.000427	0.00099	CcSEcCtD
Amiloride—Decreased appetite—Doxorubicin—testicular cancer	0.000421	0.000978	CcSEcCtD
Amiloride—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000418	0.000971	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—testicular cancer	0.000418	0.00097	CcSEcCtD
Amiloride—Pain—Doxorubicin—testicular cancer	0.000414	0.000962	CcSEcCtD
Amiloride—Constipation—Doxorubicin—testicular cancer	0.000414	0.000962	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—testicular cancer	0.000414	0.000961	CcSEcCtD
Amiloride—Asthenia—Methotrexate—testicular cancer	0.000401	0.000932	CcSEcCtD
Amiloride—Feeling abnormal—Doxorubicin—testicular cancer	0.000399	0.000927	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000396	0.00092	CcSEcCtD
Amiloride—Pruritus—Methotrexate—testicular cancer	0.000396	0.000919	CcSEcCtD
Amiloride—Abdominal pain—Doxorubicin—testicular cancer	0.000383	0.000889	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—testicular cancer	0.000383	0.000889	CcSEcCtD
Amiloride—SLC9A1—Metabolism—HPGDS—testicular cancer	0.000378	0.00619	CbGpPWpGaD
Amiloride—Asthenia—Epirubicin—testicular cancer	0.000376	0.000872	CcSEcCtD
Amiloride—Pruritus—Epirubicin—testicular cancer	0.000371	0.00086	CcSEcCtD
Amiloride—Dizziness—Methotrexate—testicular cancer	0.00037	0.000859	CcSEcCtD
Amiloride—Diarrhoea—Epirubicin—testicular cancer	0.000358	0.000832	CcSEcCtD
Amiloride—Vomiting—Methotrexate—testicular cancer	0.000356	0.000826	CcSEcCtD
Amiloride—Rash—Methotrexate—testicular cancer	0.000353	0.000819	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—testicular cancer	0.000353	0.000818	CcSEcCtD
Amiloride—Headache—Methotrexate—testicular cancer	0.000351	0.000814	CcSEcCtD
Amiloride—Asthenia—Doxorubicin—testicular cancer	0.000348	0.000807	CcSEcCtD
Amiloride—Dizziness—Epirubicin—testicular cancer	0.000346	0.000804	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—testicular cancer	0.000343	0.000796	CcSEcCtD
Amiloride—Vomiting—Epirubicin—testicular cancer	0.000333	0.000773	CcSEcCtD
Amiloride—Nausea—Methotrexate—testicular cancer	0.000332	0.000772	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—testicular cancer	0.000332	0.00077	CcSEcCtD
Amiloride—Rash—Epirubicin—testicular cancer	0.00033	0.000767	CcSEcCtD
Amiloride—SLC9A1—Disease—H2AFZ—testicular cancer	0.00033	0.0054	CbGpPWpGaD
Amiloride—Dermatitis—Epirubicin—testicular cancer	0.00033	0.000766	CcSEcCtD
Amiloride—Headache—Epirubicin—testicular cancer	0.000328	0.000762	CcSEcCtD
Amiloride—Dizziness—Doxorubicin—testicular cancer	0.00032	0.000744	CcSEcCtD
Amiloride—Nausea—Epirubicin—testicular cancer	0.000311	0.000722	CcSEcCtD
Amiloride—Vomiting—Doxorubicin—testicular cancer	0.000308	0.000715	CcSEcCtD
Amiloride—Rash—Doxorubicin—testicular cancer	0.000306	0.000709	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—testicular cancer	0.000305	0.000709	CcSEcCtD
Amiloride—SLC9A1—Disease—KITLG—testicular cancer	0.000304	0.00497	CbGpPWpGaD
Amiloride—Headache—Doxorubicin—testicular cancer	0.000304	0.000705	CcSEcCtD
Amiloride—Nausea—Doxorubicin—testicular cancer	0.000288	0.000668	CcSEcCtD
Amiloride—SLC9A1—Metabolism—STK11—testicular cancer	0.000275	0.0045	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGFR3—testicular cancer	0.000226	0.00369	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KIT—testicular cancer	0.000207	0.00339	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HPGDS—testicular cancer	8.19e-05	0.00134	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HPGDS—testicular cancer	7.63e-05	0.00125	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—STK11—testicular cancer	5.95e-05	0.000974	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—STK11—testicular cancer	5.54e-05	0.000908	CbGpPWpGaD
